Connection
Mario Enrico Canonico to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Mario Enrico Canonico has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.660 |
|
|
|
-
Canonico ME, Hess CN, Cannon CP. In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show? Curr Atheroscler Rep. 2023 07; 25(7):381-389.
Score: 0.660